Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$2.59 - $3.36 $280,310 - $363,646
-108,228 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$3.11 - $4.87 $11,500 - $18,009
-3,698 Reduced 3.3%
108,228 $363,000
Q1 2021

May 14, 2021

BUY
$3.66 - $7.67 $93,908 - $196,796
25,658 Added 29.74%
111,926 $482,000
Q4 2020

Feb 02, 2021

SELL
$3.03 - $5.51 $6,656 - $12,105
-2,197 Reduced 2.48%
86,268 $358,000
Q3 2020

Nov 05, 2020

BUY
$2.9 - $4.29 $256,548 - $379,514
88,465 New
88,465 $297,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $112M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.